
Two Cancer Drugs Show Surprising Promise in Treating Alzheimer’s
In the U.S. alone, seven million people live with Alzheimer’s disease, yet treatment options remain limited. Although cases are expected to triple by 2050, only a handful of drugs are currently approved by the Food and Drug Administration (FDA), none of …